USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 15:44 PM 2012

NYSE 8086.27 3.29 Index Moved Up

NASDAQ 2927.49 11.63 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ACUR and HSP...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Acura Pharmaceuticals Inc. and

Hospira Inc

Volatility

Matrix

Run Correlation

Diversification

Good diversification

Overlapping area represents amount of risk that can be diversified away by holding Acura Pharmaceuticals Inc. and Hospira Inc in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.09

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	87.5%
Values	Daily Returns

Suggest

Acura Pharmaceuticals Inc.

Profile

3.24

Intraday

One Month

^0.01

0.31%

ACUR

NCM

Acura Pharmaceuticals Inc.

P/E	16.91	Day Low	3.20
Open	3.26	P/B Ratio	3.85
Market Cap	146.8M	Volume	48556
Sector	Healthcare	Last Close	3.23
Short Ratio	27.30	Last Traded	2/9/2012
Year High	6.80	Percent Change	0.31%
EBITDA	9.6M	Year Low	2.28
Absolute Change	0.01	Time	Not Applicable
Book Value	0.838	EPS	0.191
Day High	3.31	Industry	Drug Delivery
Target Price	8.00	Current EPS	0.191
Current PE	16.91	This Year PE	Not Applicable

Hospira Inc

Profile

34.15

Intraday

One Month

^(0.60)

1.73%

HSP

NYSE

Hospira Inc

P/E	22.12	Day Low	33.71
Open	34.70	P/B Ratio	1.80
Market Cap	5.625B	Volume	1892261
Sector	Healthcare	Last Close	34.75
Short Ratio	2.80	Last Traded	2/9/2012
Year High	59.20	Percent Change	1.73%
EBITDA	791.6M	Year Low	26.92
Absolute Change	0.60	Time	Not Applicable
Book Value	19.359	EPS	1.571
PEG Ratio	2.57	Employees	14,000
Day High	34.76	Industry	Drug Delivery
Target Price	32.92	Current EPS	1.571
This Year EPS	2.99	Next Year EPS	2.43
Current PE	22.12	This Year PE	11.62
Next Year PE	14.30	Dividend	Not Applicable